225 related articles for article (PubMed ID: 33574490)
1. Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.
Biayna J; Mazuelas H; Gel B; Terribas E; Dumbovic G; Rosas I; Fernández-Rodriguez J; Blanco I; Castellanos E; Carrió M; Lazaro C; Serra E
Sci Rep; 2021 Feb; 11(1):3661. PubMed ID: 33574490
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.
Hinman MN; Sharma A; Luo G; Lou H
Mol Cell Biol; 2014 Jun; 34(12):2188-97. PubMed ID: 24710274
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of the neurofibromatosis type I pre-mRNA.
Barron VA; Lou H
Biosci Rep; 2012 Apr; 32(2):131-8. PubMed ID: 22115364
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA.
Zhu H; Hinman MN; Hasman RA; Mehta P; Lou H
Mol Cell Biol; 2008 Feb; 28(4):1240-51. PubMed ID: 18086893
[TBL] [Abstract][Full Text] [Related]
8. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
9. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
10. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
[TBL] [Abstract][Full Text] [Related]
11. NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.
Metheny LJ; Skuse GR
Exp Cell Res; 1996 Oct; 228(1):44-9. PubMed ID: 8892969
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors.
Nishi T; Saya H
Cancer Metastasis Rev; 1991 Dec; 10(4):301-10. PubMed ID: 1786631
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
14. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N; Miller SJ
Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
[TBL] [Abstract][Full Text] [Related]
15. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
Abramowicz A; Gos M
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
[TBL] [Abstract][Full Text] [Related]
16. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.
Gutmann DH; Cole JL; Collins FS
J Neurosci Res; 1994 Feb; 37(3):398-405. PubMed ID: 8176761
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
Scheurlen WG; Senf L
Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
